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Abstract
Background: Older women have poorer survival from breast cancer, which may be at least partly due to poor breast
cancer awareness leading to delayed presentation and more advanced stage at diagnosis. In a randomised trial, an
intervention to promote early presentation of breast cancer in older women increased breast cancer awareness at 1 year
compared with usual care (24 versus 4%). We examined its effectiveness in routine clinical practice.
Methods: We piloted the intervention delivered by practising health professionals to women aged about 70 in four
breast screening services. We measured the effect on breast cancer awareness at 1 year compared with comparison
services, where women did not receive the intervention.
Results: At 1 year, 25% of women in pilot services were breast cancer aware compared with 4% in comparison services
(p = 0.001). The components of breast cancer awareness were knowledge of breast cancer non-lump symptoms (pilot:
63% vs comparison: 82% at 1 year; OR = 2.56, 95% CI 1.92-3.42), knowledge of age related risk (pilot: 8% vs comparison:
36% at 1 year; OR = 5.56, 95% CI 4.0-7.74) and reported breast checking (pilot: 70% vs comparison: 78% at 1 year; OR = 1.
49, 95% CI 1.13-1.96).
Conclusion: The intervention may be as effective in routine clinical practice as in a randomised controlled trial. This
intervention has the potential to reduce patient delay in the diagnosis of breast cancer in older women.
Trial registration: The PEP trial was registered with the International Standard Registered Clinical/soCial sTudy Number
(ISRCTN) as a clinical trial (ISRCTN31994827) on 3rd October 2007.
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Background
Women in the United Kingdom (UK) have poorer survival
from breast cancer compared to other similar countries
[1, 2]. While this may be due to delays in diagnosis or
treatment once in the health care system, or less aggres-
sive treatment once in the health care system, patients
presenting when breast cancer has already reached a late
stage may also contribute. Delayed presentation of breast
cancer is more common in older than younger women [3]
and older women are more likely to be diagnosed with
more advanced disease [4]. Not recognising breast cancer
symptoms is a risk factor for delayed presentation [3, 5].
Improving symptom recognition to facilitate prompt pres-
entation in this population may improve survival.
The Promoting Early Presentation (PEP) Intervention
was developed to provide older women with the know-
ledge, motivation, confidence and skills to present
promptly on discovering a breast symptom. It is a brief,
scripted, one-to-one intervention delivered by a health
professional in a positive, motivational and collaborative
style and supported by a booklet [6, 7]. In a randomised
controlled trial (RCT), the PEP Intervention delivered by
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research radiographers, increased breast cancer awareness
in women around the age of 70 compared with usual care
after 1 year (breast cancer aware: PEP Intervention 24% vs
usual care 4%) [7]. In a pilot in the National Health Ser-
vice (NHS) Breast Screening Programme, in which the
PEP Intervention was delivered as part of routine clinical
practice by NHS radiographers to women of a similar age,
breast cancer awareness increased from 4% before the
intervention to 38% 1 month later [8]. We aimed to meas-
ure whether this effect was maintained after 1 year to the
same extent as in the trial.
Methods
Women attending for their final invited screening ap-
pointment at four NHS breast screening services where
the PEP Intervention was offered (pilot services) and at
a comparison service where the PEP Intervention was
not offered (comparison service) were invited to take
part during May 2011 and April 2012. Recruitment is
described in more detail elsewhere [8] and informed
consent was obtained from all participants.
Women completed a questionnaire before their mam-
mogram. The questionnaire included a validated meas-
ure of breast cancer awareness [9]. Women were
considered breast cancer aware if they recognised five or
more non-lump symptoms (change in the position of
nipple, pulling in of nipple, pain in breasts or armpit,
puckering or dimpling of breast skin, discharge or bleed-
ing from nipple, nipple rash, redness of breast skin,
changes in the size of breast or nipple, changes in the
shape of breast or nipple), knew that the risk of breast
cancer increased with age and reported checking their
breasts at least once a month. The questionnaire also
asked for details of ethnic group, whether they lived with
a husband or partner and the age they had left full-time
education. At 1 year, the women were sent a further
questionnaire to measure breast cancer awareness.
We excluded from the analysis women who reported
being treated for breast cancer during that year. We in-
cluded only women who had provided data at baseline
and 1 year on all three relevant questions. We used
women’s responses to the three breast cancer awareness
questions to calculate a breast cancer awareness score
(range 0-3). Women were considered breast cancer
aware if they scored 3 out of 3, meaning that: they knew
that risk of breast cancer increases with age (knowledge
of age-related risk), could identify five or more non-
lump symptoms of breast cancer (knowledge of non-
lump symptoms) and reported checking their breasts at
least once a month.
To examine change in breast cancer awareness from
baseline to 1 year, we used repeated measures logistic re-
gression models. These logistic regression models (or
generalised estimated equations) allow us to model the
relationship between covariates of interest (e.g. receiving
PEP Intervention or not, time) and an outcome (breast
cancer awareness) measured at multiple time points, ac-
counting for the correlated nature of the data. These cal-
culated odd ratios (ORs) with 95% confidence intervals
(CI) for odds of being breast cancer aware (i.e. scoring 3
in the breast cancer awareness score) in women who re-
ceived the PEP Intervention compared to those in the
comparison service. We also carried our similar analyses
for the three component questions of the breast cancer
awareness score: for the odds of knowing the age-related
risk of breast cancer and non-lump symptoms, and for
breast checking at least once a month. We examined the
effect on the odds ratios of controlling for differences in
age, whether they had a husband/partner, age at leaving
full-time education and Index of Multiple Deprivation
(IMD), a score based on area of residence using data
from a number of sources, which provides an estimate
of socioeconomic deprivation.
Results
In the four pilot breast screening services, 356 women
provided analysable breast cancer awareness data at 1
year, representing 72% of the 497 who completed the
baseline questionnaire (2 had been diagnosed with breast
cancer, 93 did not respond at 1 year, and 46 did not
complete all three relevant questions). Details of non-
responders at 1 month are given in our previous paper
[8]. Those excluded from the analysis were more likely
to be living in socioeconomically deprived areas and less
likely to be breast cancer aware at baseline than those
who were included.
In the comparison services, 661 women provided ana-
lysable breast cancer awareness data, representing 75% of
the 880 who completed the baseline questionnaire (4 had
been diagnosed with breast cancer, 154 did not respond at
1 year, and 61 did not complete all three relevant ques-
tions). We found no demographic differences between
those included in the analysis and those not, although
women who were excluded were less likely to be breast
cancer aware at baseline.
There were some demographic differences between
women in the pilot and comparison services: women in
the pilot services were slightly older, less likely to be liv-
ing with a husband or partner, less socioeconomically
deprived and more educated (described in more detail in
our previous paper [8]).
Women who received the PEP Intervention were signifi-
cantly more likely to be breast cancer aware at 1 year than
women in the comparison service (25 vs. 4%; Table 1).
This was true for all components of the breast cancer
awareness score, the effect being greatest for knowledge
that the risk of breast cancer increases with age (Table 1).
Adjusting for demographic differences (age, living with a
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husband or partner, age left full-time education and IMD
score) between the groups made little difference to the
odds ratios (Table 1).
Discussion
An intervention to promote early presentation of breast
cancer among older women delivered by NHS mammo-
graphers in routine clinical practice raises breast cancer
awareness to a similar extent as in a research setting. All
three components of breast cancer awareness were in-
creased in women receiving the PEP Intervention when
compared to the comparison service at 1 year. The most
marked effect was seen in women’s knowledge of age-
related risk, albeit knowledge was still much lower than
for the other components of breast cancer awareness.
The intervention was conducted at the final scheduled
mammography appointment, so it is surprising that the
level of awareness in women was in fact not higher than
found. However, previous studies with older women
have also found low levels of breast cancer awareness
[10]. An explanation for this could be the role of sub-
jective norm, being advice from friends, family and
health professionals about mammography, which has
been shown previously to influence breast screening up-
take [11]. This could lead women to feel less engaged
with their decision and therefore be less breast cancer
aware. Alternatively, the women who attend screening
may be those who do have poor knowledge of breast
symptoms, personal risk and feel less confident about
detecting a breast change and this might be their reason
for attending screening.
Similar increases in magnitude for women’s knowledge
of age-related risk were found in the implementation of
the PEP Intervention into routine clinical practice to
those found in the RCT [7], which is very encouraging.
Although the overall level of knowledge is lower than
the other two components, the level of knowledge from
baseline has improved greatly. Previously, women have
expressed surprise that their risk of developing cancer
increased with age, but that they would no longer be in-
vited for mammograms [6]. As no more invitations for
screening can lead women to infer that risk diminishes
with age, this is likely to be a reason for this component
of breast cancer awareness being the most difficult to
achieve high levels of awareness. In addition, modelling
and demonstration for breast checking and non-lump
symptoms may have reinforced those messages and re-
sulted in those two components being more potent. It is
important to communicate the message to older women
that risk increases with age when they interact with a
health professional.
The high response rates and use of a validated meas-
ure of breast cancer awareness [9] are strengths of this
study. We found no evidence that the increase in breast
cancer awareness was due to the questionnaire measur-
ing breast cancer awareness itself (an effect known as
the ‘mere measurement effect’ [12]) because there was
only a very small increase in breast cancer awareness in
the comparison service.
There were demographic differences between women in
the pilot services and the comparison service. However, we
think this is unlikely to explain our findings – controlling
for this made little difference to the magnitude of the effect.
We carried out the analysis only on those women with
complete data at 1 year. The women who were excluded
from this were less likely to have been breast cancer
aware at baseline. This could have spuriously inflated
differences in breast cancer awareness at 1 year between
Table 1 Adjusted and unadjusted results for breast cancer awareness at baseline and 1 year
Comparison service
(n = 661)
PEP Intervention service
(n = 356)
Odds ratio
(PEP Intervention vs comparison
service (95% CI, p value)
Baseline One year Baseline One year Unadjusted Adjustedb
Breast cancer awarenessa
Number (%) breast cancer aware
22 (3.3) 29 (4.4) 19 (5.3) 90 (25.3) 6.97 (4.56-10.63), <0.001 8.13 (4.30-15.33), <0.001
Knowledge of breast cancer symptoms
Number (%) who identified five or more
non-lump symptoms
374 (56.6) 418 (63.2) 198 (55.6) 291 (81.7) 2.56 (1.92-3.42), <0.001 2.54 (1.72-3.75), <0.001
Knowledge of age-related risk
Number (%) who identified that a 70 year
old woman is more at risk of breast cancer
than a younger woman or woman of any age
57 (8.6) 55 (8.3) 52 (14.6) 129 (36.2) 5.56 (4.0-7.74), <0.001 5.38 (3.28-8.79), <0.001
Breast checking
Number (%) who reported checking their
breasts at least once a month
384 (58.1) 460 (69.6) 184 (51.7) 277 (77.8) 1.49 (1.13-1.96), 0.005 1.74 (1.18-2.56), 0.005
Abbreviation: CI Confidence Intervals
aA woman scored three points on the breast cancer awareness score (and so was considered to be breast cancer aware) if she: identified at least five non-lump
symptoms of breast cancer (one point), identified that a 70 year old woman is most at risk of breast cancer (one point) and reported checking her breasts at least
once a month (one point)
bAdjusted for age, living with a husband or partner, age left full-time education and Index of Multiple Deprivation score
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PEP Intervention and comparison services, but the dif-
ferences are so striking that it is very unlikely to explain
them fully.
In a 2013 report, the All Party Parliamentary Group on
Breast Cancer recommended that the PEP Intervention be
more widely implemented so that the effect on breast can-
cer mortality can be evaluated [13]. One- to-one interven-
tions such as the PEP Intervention and public awareness
campaigns such as the national Be Clear on Cancer cam-
paign to promote early presentation in women aged 70+
with breast symptoms [14] may ultimately lead to improv-
ing the UK’s poor breast cancer survival compared with
other high income countries with similar health care sys-
tems. It is currently unknown whether increased breast
awareness, and what level of awareness, will result in re-
duced breast cancer mortality. However, given that
women with poor awareness of symptoms have been
shown to delay presentation [3], this could suggest an in-
fluence of breast awareness in mortality. Self-referral for
screening, symptomatic breast clinic attendances and
breast cancer mortality will be monitored in this group of
women in the longer term.
The success of the intervention in a mammography set-
ting has led to further adaptation of the intervention to en-
able it to be transferable to other settings such as general
practice [15], to additionally target those who do not attend
for screening. Implemented into general practice by prac-
tice nurses, breast cancer awareness increased between
baseline and 1 year by a similar magnitude found in the
present study [15]. Cost effective alternatives of the PEP
Intervention which have been shown to increase breast
cancer awareness, but not to the same magnitude, include a
written version of the intervention [16] and also the booklet
which supported the PEP Intervention [7]. These could po-
tentially be used to reach greater numbers of older women.
Conclusion
Women who received the PEP intervention in routine
clinical practice demonstrated similar levels of breast
cancer awareness at 1 year as those women receiving the
PEP intervention in a randomised controlled trial. Fol-
low up showing the effect of this kind of intervention in
routine clinical practice after 1 year is unprecedented.
These findings can usefully inform future interventions
aimed at promoting the early presentation of breast can-
cer in older women.
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